Infections Complicating Congenital Immunodeficiency Syndromes

  • John C. Christenson
  • Harry R. Hill


Nothing is more challenging to the physician than the management of a serious infection in an immunocompromised host. Under such circumstances, the clinician must draw upon all of his knowledge of microbiology and antimicrobial therapy; in addition, he must have a firm understanding of the host-defense abnormality underlying that individual patient’s disease. As indicated by Stollerman, we can no longer have a primarily parasite-oriented approach to infectious diseases: we must include host factors in the data on which we base potentially lifesaving decisions.


Otitis Medium Chronic Granulomatous Disease Severe Combine Immunodeficiency Disease Immunodeficient Patient Recurrent Otitis Medium 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Stollerman GH: Immunologic deficiencies in the training of physicians. J Chronic Dis 26: 679–688, 1973.PubMedGoogle Scholar
  2. 2.
    Hermans PE, Diaz-Buxo JA, Stobo JD: Idiopathic late-onset immunoglobulin deficiency. Am J Med 61: 221–237, 1976.PubMedGoogle Scholar
  3. 3.
    Albano EA, Pizzo PA: The evolving population of immunocompromised children. Pediatr Infect Dis J 7: S79–S86, 1988.PubMedGoogle Scholar
  4. 4.
    Hill HR: Evaluating the patient with recurrent infections. South Med J 70: 230–235, 1977.PubMedGoogle Scholar
  5. 5.
    Hill HR: Laboratory aspects of immune deficiency in children. Pediatr Clin North Am 27: 805–830, 1980.PubMedGoogle Scholar
  6. 6.
    Hill HR: Immunodeficiency diseases. In Stefanini M, Benson E (eds): Progress in Clinical Pathology. New York, Grune & Stratton, 1981, pp 205–238.Google Scholar
  7. 7.
    Johnston RB Jr, Janeway CA: The child with frequent infections: Diagnostic considerations. Pediatrics 43: 596–600, 1969.PubMedGoogle Scholar
  8. 8.
    Johnston RB Jr, Lawton AR III, Cooper MD: Disorders of host defense against infection: Pathophysiologic and diagnostic considerations. Med Clin North Am 57: 421–440, 1973.PubMedGoogle Scholar
  9. 9.
    Shyur S-D, Hill HR: Immunodeficiency in the 1990s. Pediatr Infect Dis J 10: 595–611, 1991.PubMedGoogle Scholar
  10. 10.
    Dingle JH, Badger GF, Jordan WS Jr: Illness in the Home. Cleveland, Press of Case Western Reserve University, 1964.Google Scholar
  11. 11.
    Ammann AJ: T cell and T-B cell immunodeficiency disorders. In Miller ME (ed): The Child with Recurrent Infection. Philadelphia, Saunders, 1977, pp 293–311.Google Scholar
  12. 12.
    Groshong T, Horowitz S, Lovchik J, et al: Chronic cytomegalovirus infection, immunodeficiency, and monoclonal gammopathy-antigen-driven malignancy. J Pediatr 88: 217–223, 1976.PubMedGoogle Scholar
  13. 13.
    Kretschmer R, Say B, Brown D, et al: Congenital aplasia of the thymus gland (DiGeorge’s syndrome). N Engl J Med 279: 1295–1301, 1968.PubMedGoogle Scholar
  14. 14.
    Lawlor GJ Jr, Ammann AJ, Wright WC Jr, et al: The syndrome of cellular immunodeficiency with immunoglobulins. J Pediatr 84: 183–192, 1974.PubMedGoogle Scholar
  15. 15.
    Jondal M, Holm G, Wigzell H: Surface markers on human T and B lymphocytes. I. A large population of lymphocytes forming nonimmune rosettes with sheep red blood cells. J Exp Med 136: 207–215, 1972.PubMedGoogle Scholar
  16. 16.
    Goldman AS, Goldblum RM: Primary deficiencies in humoral immunity, in Miller ME (ed): The Child with Recurrent Infection. Philadelphia, Saunders, 1977, pp 277–291.Google Scholar
  17. 17.
    Hecht F, McCaw BK, Koler RD: Ataxia-telangiectasia-clonal growth of translocation lymphocytes. N Engl J Med 289: 286–291, 1973.PubMedGoogle Scholar
  18. 18.
    Shackelford PG, Polmar SH, Mayus JL, et al: Spectrum of IgG subclass deficiency in children with recurrent infections: Prospective study. J Pediatr 108: 647–653, 1986.PubMedGoogle Scholar
  19. 19.
    Heiner DC: Recognition and management of IgG subclass deficiencies. Pediatr Infect Dis J 6: 235–238, 1987.PubMedGoogle Scholar
  20. 20.
    Umetsu DT, Ambrosino DM, Quinti I, et al: Recurrent sinopulmonary infection and impaired antibody response to bacterial capsular polysaccharide antigen in children with selective IgG-subclass deficiency. N Engl J Med 313: 1247–1251, 1985.PubMedGoogle Scholar
  21. 21.
    Berger M: Immunoglobulin G subclass determination in diagnosis and management of antibody deficiency syndromes. J Pediatr 110: 325–328, 1987.PubMedGoogle Scholar
  22. 22.
    Ambrosino DM, Siber GR, Chilmonczyk BA: An immunodeficiency characterized by impaired antibody responses to polysaccharides. N Engl J Med 316: 790–793, 1987.PubMedGoogle Scholar
  23. 23.
    Gigliotti F, Herrod HG, Kalwinsky DK, et al: Immunodeficiency associated with recurrent infections and an isolated in vivo inability to respond to bacterial polysaccharides. Pediatr Infect Dis J 7: 417–420, 1988.PubMedGoogle Scholar
  24. 24.
    Alper CA, Colten HR, Gear JSS, et al: Homozygous human C3 deficiency. J Clin Invest 57: 222–229, 1976.PubMedGoogle Scholar
  25. 25.
    Ballow M, Shira JE, Harden L, et al: Complete absence of the third component of complement in man. J Clin Invest 56: 703–710, 1975.PubMedGoogle Scholar
  26. 26.
    Boyer JT, Gall EP, Norman ME, et al: Hereditary deficiency of the seventh component of complement. J Clin Invest 56: 905–913, 1975.PubMedGoogle Scholar
  27. 27.
    Leddy JP, Frank MM, Gaitner I, et al: Hereditary deficiency of the sixth component of complement in man. J Clin Invest 53: 544–553, 1974.PubMedGoogle Scholar
  28. 28.
    Miller ME, Seals J, Kaye R, et al: A familial, plasma-associated defect of phagocytosis: A new cause of recurrent bacterial infections. Lancet 2: 60–63, 1968.Google Scholar
  29. 29.
    Petersen BH, Graham JA, Brooks GF: Human deficiency of the eighth component of complement. J Clin Invest 57: 283–290, 1976.PubMedGoogle Scholar
  30. 30.
    Petersen BH, Lee TJ, Snyderman RJ, et al: Neisseria meningitidis and Neisseria gonorrheae bacteremia associated with C6, C7, or C8 deficiency. Ann Intern Med 90: 917–920, 1979.PubMedGoogle Scholar
  31. 31.
    Rosenfeld SI, Baum J, Steigbigel RT, et al: Hereditary deficiency of the fifth component of complement in man. J Clin Invest 57: 1635–1643, 1976.PubMedGoogle Scholar
  32. 32.
    Curnutte JT, Whitten DM, Babior BM: Defective Superoxide production by granulocytes from patients with chronic granulomatous disease. N Engl J Med 290: 593–596, 1974.PubMedGoogle Scholar
  33. 33.
    Hill HR, Quie PG: Raised serum-IgE levels and defective neutrophil chemotaxis in three children with eczema and recurrent bacterial infections. Lancet 1: 183–187, 1974.PubMedGoogle Scholar
  34. 34.
    Hill HR, Quie PG: Defective neutrophil chemotaxis associated with hyperimmunoglobulinemia E. In Bellanti JA, Dayton DH (eds): The Phagocytic Cell in Host Resistance. New York, Raven Press, 1975, pp 249–266.Google Scholar
  35. 35.
    Holmes B, Park BH, Malawista SE, et al: Chronic granulomatous disease in females: A deficiency of leukocyte glutathione peroxidase. N Engl J Med 283: 217–221, 1970.PubMedGoogle Scholar
  36. 36.
    Johnston RB Jr, Baehner RL: Chronic granulomatous disease: Correlation between pathogenesis and clinical findings. Pediatrics 48: 730–739, 1971.PubMedGoogle Scholar
  37. 37.
    Miller ME, Oski FA, Harris MB: Lazy-leukocyte syndrome. Lancet 1: 665–669, 1971.PubMedGoogle Scholar
  38. 38.
    Oh MK, Rodey GE, Good RA, et al: Defective candicidal capacity of polymorphonuclear leukocytes from patients with chronic granulomatous disease of childhood. J Pediatr 75: 300–303, 1969.Google Scholar
  39. 39.
    Quie PG, Hill HR: Granulocytopathies. Dis Mon 1: 1–32, 1973.Google Scholar
  40. 40.
    Quie PG: Bactericidal function of human polymorphonuclear leukocytes. Pediatrics 50: 264–270, 1972.PubMedGoogle Scholar
  41. 41.
    Van Scoy RE, Hill HR, Ritts RE Jr, et al: Familial neutrophil chemotaxis defect, recurrent bacterial infections, mucocutaneous candidiasis and hyperimmunoglobulinemia E. Ann Intern Med 82: 766–771, 1975.PubMedGoogle Scholar
  42. 42.
    Baehner RL, Nathan DG: Quantitative nitroblue tetrazolium test in chronic granulomatous disease. N Engl J Med 278: 971–980, 1968.PubMedGoogle Scholar
  43. 43.
    Park BH: The use and limitations of the nitroblue tetrazolium test as a diagnostic aid. J Pediatr 78: 376–378, 1971.PubMedGoogle Scholar
  44. 44.
    Cheson BD, Christensen RL, Sperling R, et al: The origin of the chemiluminescence of phagocytizing granulocytes. J Clin Invest 58: 789–796, 1976.PubMedGoogle Scholar
  45. 45.
    Shigeoka AO, Santos JI, Hill HR: Functional analysis of neutrophil granulocytes from healthy, infected and stressed neonates. J Pediatr 95: 454–469, 1979.PubMedGoogle Scholar
  46. 46.
    Allen RC, Stjernholm RL, Steele RH: Evidence for the generation of an electronic excitation state(s) in human polymorphonuclear leukocytes and its participation in bactericidal activity. Biochem Biophys Res Commun 47: 679–684, 1972.PubMedGoogle Scholar
  47. 47.
    Allen RC, Yevich SJ, Orth RW, et al: The Superoxide anion and singlet molecular oxygen: Their role in the microbicidal activity of the polymorphonuclear leukocyte. Biochem Biophys Res Commun 60: 909–917, 1974.PubMedGoogle Scholar
  48. 48.
    Rosen H, Klebanoff SJ: Chemiluminescence and Superoxide production by myeloperoxidase-deficient leukocytes. J Clin Invest 58: 50–60, 1976.PubMedGoogle Scholar
  49. 49.
    Shigeoka AO, Hill HR: Recurrent pseudomonas infection associated with neutrophil dysfunction. Scand J Infect Dis 10: 307–311, 1978.PubMedGoogle Scholar
  50. 50.
    Stevens P, Winston DJ, Van Dyke K: In vitro evaluation of opsonic and cellular granuloctye function by luminol-dependent chemiluminescence: Utility in patients with severe neutropenia and cellular deficiency states. Infect Immun 22: 41–51, 1978.PubMedGoogle Scholar
  51. 51.
    Quie PG, White JG, Holmes B, et al: In vitro bactericidal capacity of human polymorphonuclear leukocytes: Diminished activity in chronic granulomatous disease of childhood. J Clin Invest 46: 668–679, 1967.PubMedGoogle Scholar
  52. 52.
    Ward PA, Cochrane CG, Muller-Eberhard HJ: The role of serum complement in chemotaxis of leukocytes in vitro. J Exp Med 122: 327–346, 1965.PubMedGoogle Scholar
  53. 53.
    Hill HR, Hogan NA, Mitchell TG, et al: Evaluation of a cyto-centrifuge method for measuring neutrophil granulocyte chemotaxis. J Lab Clin Med 86: 703–710, 1975.PubMedGoogle Scholar
  54. 54.
    Cutler JE: A simple in vitro method for studies on chemotaxis. Proc Soc Exp Biol Med 147: 471–474, 1974.PubMedGoogle Scholar
  55. 55.
    Nelson RD, Quie PG, Simmons RL: Chemotaxis under agarose: A new and simple method for measuring chemotaxis and spontaneous migration of human polymorphonuclear leukocytes and monocytes. J Immunol 115: 1650–1656, 1975.PubMedGoogle Scholar
  56. 56.
    Miller ME: Leukocyte movement—in vitro and in vivo correlates. J Pediatr 83: 1104–1106, 1973.PubMedGoogle Scholar
  57. 57.
    Hill HR, Quie PG, Pabst HF, et al: Defect in neutrophil granulocyte chemotaxis in Job’s syndrome or recurrent “cold” staphylococcal abscesses. Lancet 2: 617–619, 1974.PubMedGoogle Scholar
  58. 58.
    Ayoub EM, Dudding BA, Cooper MD: Dichotomy of antibody response to group A streptococcal antigen in Wiskott-Aldrich syndrome. J Lab Clin Med 72: 183–187, 1968.Google Scholar
  59. 59.
    Blaese RM, Strober W, Waldmann TA: Immunodeficiency in Wiskott-Aldrich syndrome. Birth Defects 11: 250–254, 1975.PubMedGoogle Scholar
  60. 60.
    Ezer G, Soothill JF: Intracellular bactericidal effects of rifampin in both normal and chronic granulomatous disease polymorphs. Arch Dis Child 49: 463–466, 1974.PubMedGoogle Scholar
  61. 61.
    Phillippart AI, Colodny AH, Baehner RL: Continuous antibiotic therapy in chronic granulomatous disease: Preliminary communication. Pediatrics 50: 923–925, 1972.Google Scholar
  62. 62.
    Hahn HH, Beaty HN: Transtracheal aspiration in the evaluation of patients with pneumonia. Ann Intern Med 72: 183–187, 1970.PubMedGoogle Scholar
  63. 63.
    Hughes JR, Sinha DP, Cooper MR, et al: Lung tap in childhood. Pediatrics 41: 477–484, 1969.Google Scholar
  64. 64.
    Finaldn M: Diagnostic lung puncture. Pediatrics 44: 471–485, 1969.Google Scholar
  65. 65.
    Kahn FW, Jones JM: Analysis of bronchoalveolar lavage specimens from immunocompromised patients with a protocol applicable in the microbiology laboratory. J Clin Microbiol 26: 1150–1155, 1988.PubMedGoogle Scholar
  66. 66.
    Pattishall EN, Noyes BE, Orenstein DM: Use of bronchoalveolar lavage in immunocompromised children with pneumonia. Pediatr Pulmonol 5: 1–5, 1988.PubMedGoogle Scholar
  67. 67.
    Wolff LJ, Bartlett MS, Baehner RL, et al: The causes of interstitial pneumonitis in immunocompromised children: An aggressive systematic approach to diagnosis. Pediatrics 60: 41–49, 1977.PubMedGoogle Scholar
  68. 68.
    Coonrod JD, Rytel MW: Determination of aetiology of bacterial meningitis by counterimmunoelectrophoresis. Lancet 11: 1154–1157, 1972.Google Scholar
  69. 69.
    Hill HR: Rapid detection of specific identification of infections due to group B streptococci by counterimmunoelectrophoresis. In Borodina VM, Meisel MN (eds): Microbiology 1975. Washington, DC; American Society for Microbiology, 1975, vol 44, pp 84–88.Google Scholar
  70. 70.
    Rytel MW: Counterimmunoelectrophoresis in diagnosis of infectious disease. Hosp Pract 10: 75–82, 1975.Google Scholar
  71. 71.
    Rytel MW: Rapid diagnostic methods in infectious diseases. Adv Intern Med 20: 37–60, 1975.PubMedGoogle Scholar
  72. 72.
    Edwards EH, Muehl PM, Peckinpaugh RO: Diagnosis of bacterial meningitis by counterimmunoelectrophoresis. J Lab Clin Med 80: 449–454, 1972.PubMedGoogle Scholar
  73. 73.
    Ingram DL, Anderson P, Smith DH: Countercurrent immunoelectrophoresis in the diagnosis of systemic diseases caused by Haemophilus influenzae, type b. J Pediatr 81: 1156–1159, 1972.PubMedGoogle Scholar
  74. 74.
    Smith EWP, Ingram DL: Counterimmunoelectrophoresis in Haemophilus influenzae type b epiglottitis and pericarditis. J Pediatr 86: 571–573, 1975.PubMedGoogle Scholar
  75. 75.
    Coonrod JD, Rytel MW: Detection of type-specific pneumococcal antigens by counterimmunoelectrophoresis. I. Methodology and immunologic properties. J Lab Clin Med 81: 770–777, 1973.PubMedGoogle Scholar
  76. 76.
    Coonrod JD, Leach RP: Antigenemia in fulminant pneumococcemia. Ann Intern Med 84: 561–563, 1976.PubMedGoogle Scholar
  77. 77.
    Fossieck B Jr, Craig R, Paterson PY: Counterimmunoelectrophoresis for rapid diagnosis of meningitis due to Diplococcus pneumoniae. J Infect Dis 127: 106–109, 1973.PubMedGoogle Scholar
  78. 78.
    Ferstenfeld JE, Rytel MW: Fulminating meningococcemia with high serum level of meningococcal capsular antigen. JAMA 227: 1301–1302, 1974.PubMedGoogle Scholar
  79. 79.
    Greenwood BM, Whittle HC, Dominic-Rajkovic O: Counter-current immunoelectrophoresis in the diagnosis of meningococcal infections. Lancet 2: 519–521, 1971.PubMedGoogle Scholar
  80. 80.
    Fallon RJ: Escherichia coli K1. Lancet 1: 201, 1976.PubMedGoogle Scholar
  81. 81.
    Hill HR, Riter ME, Menge SK, et al: Rapid identification of group B streptococci by counterimmunoelectrophoresis. J Clin Microbiol 1: 188–191, 1975.PubMedGoogle Scholar
  82. 82.
    Portas MR, Hogan NA, Hill HR: Rapid specific identification of group D streptococci by counterimmunoelectrophoresis. J Lab Clin Med 88: 339–344, 1976.PubMedGoogle Scholar
  83. 83.
    Wenzel RP, Teates CD, Galapon Q, et al: Acute viral hepatitis in adults: Comparison of the radioimmunoassay and counterimmunoelectrophoresis methods of detecting HBsAg. JAMA 232: 366–368, 1975.PubMedGoogle Scholar
  84. 84.
    Cho HJ, Langford EV: Rapid detection of bovine mycoplasma antigens by counterimmunoelectrophoresis. Appl Microbiol 28: 897–899, 1974.PubMedGoogle Scholar
  85. 85.
    Pifer LL, Hughes WT, Stagno S, et al: Pneumocystis carinii infection: Evidence for high prevalence in normal and immunosuppressed children. Pediatrics 61: 35–41, 1978.PubMedGoogle Scholar
  86. 86.
    Myers JD, Pifer LL, Sale GE, et al: Value of Pneumocystis carinii antibody and antigen detection for diagnosis of Pneumocystis carinii pneumonia after marrow transplantation. Am Rev Respir Dis 120: 181–182, 1979.Google Scholar
  87. 87.
    Dorff GJ, Coonrod JD, Rytel MW: Detection by immunoelectrophoresis of antigen in sera of patients with pneumococcal bacteremia. Lancet 1: 578–579, 1971.PubMedGoogle Scholar
  88. 88.
    Shackelford PG, Campbell J, Feigin RD: Countercurrent immunoelectrophoresis in the evaluation of childhood infections. J Pediatr 85: 478–481, 1974.PubMedGoogle Scholar
  89. 89.
    Colding H, Lind I: Counterimmunoelectrophoresis in the diagnosis of bacterial meningitis. J Clin Microbiol 5: 405–409, 1977.PubMedGoogle Scholar
  90. 90.
    Feigin RD, Wong M, Shackelford PG, et al: Countercurrent immunoelectrophoresis of urine as well as of CSF and blood for diagnosis of bacterial meningitis. J Pediatr 89: 773–775, 1976.PubMedGoogle Scholar
  91. 91.
    Hill HR: Detection of bacterial antigens in meningitis, in “American Society of Clinical Pathology, Check Sample,” MB: 82-83, 1982.Google Scholar
  92. 92.
    El-Refaie M, Dulake C: Counter-current immunoelectrophoresis in the diagnosis of pneumococcal chest infections. J Clin Pathol 28: 801–806, 1975.PubMedGoogle Scholar
  93. 93.
    Michaels RH, Poziviak CS: Countercurrent immunoelectrophoresis for the diagnosis of pneumococcal pneumonia in children. J Pediatr 88: 72–74, 1976.PubMedGoogle Scholar
  94. 94.
    Bartram CE, Crowder JG, Beeler B, et al: Diagnosis of bacterial diseases by detection of serum antigens by counterimmunoelectrophoresis, sensitivity, and specificity of detecting Pseudomonas and pneumococcal antigens. J Lab Clin Med 83: 591–598, 1974.PubMedGoogle Scholar
  95. 95.
    Sottile MI, Rytel MW: Application of counterimmunoelectrophoresis in the identification of Streptococcus pneumoniae in clinical isolates. J Clin Microbiol 2: 173–177, 1975.PubMedGoogle Scholar
  96. 96.
    Harris MC, Deuber C, Polin RA, et al: Investigation of apparent false-positive urine latex particle agglutination tests for the detection of group B streptococcus antigen. J Clin Microbiol 27: 2214–2217, 1989.PubMedGoogle Scholar
  97. 97.
    Rothstein EP, Madore DV, Girone JAC, et al: Comparison of antigenuria after immunization with three Haemophilus influenzae type b conjugate vaccines. Pediatr Infect Dis J 10: 311–314, 1991.PubMedGoogle Scholar
  98. 98.
    Miller J, Sande MA, Gwaltney JM, et al: Diagnosis of pneumococcal pneumonia by antigen detection in sputum. J Clin Microbiol 7: 459–462, 1978.PubMedGoogle Scholar
  99. 99.
    Dee TH, Rytel MW: Clinical applications of counterimmunoelectrophoresis in detection of Candida serum precipitins. J Lab Clin Med 85: 161–166, 1975.PubMedGoogle Scholar
  100. 100.
    Guinan ME, Portas MR, Hill HR: The Candida precipitin test in an immunosuppressed population. Cancer 43: 299–302, 1979.PubMedGoogle Scholar
  101. 101.
    Remington JS, Gaines JD, Gilmer MA: Demonstration of Candida precipitins in human sera by counterimmunoelectrophoresis. Lancet 1: 413–415, 1972.PubMedGoogle Scholar
  102. 102.
    Jones JM: Laboratory diagnosis of invasive candidiasis. Clin Microbiol Rev 3: 32–45, 1990.PubMedGoogle Scholar
  103. 103.
    Crowder JG, White A: Teichoic acid antibodies in staphylococcal and nonstaphylococcal endocarditis. Ann Intern Med 77: 87–90, 1972.PubMedGoogle Scholar
  104. 104.
    Tuazon CV, Sheagren J: Teichoic acid antibodies in the diagnosis of serious infections with Staphylococcus aureus. Ann Intern Med 84: 543–546, 1976.PubMedGoogle Scholar
  105. 105.
    Nagel JG, Tuazon CV, Cardella TA, et al: Teichoic acid serologic diagnosis of staphylococcal endocaraditis. Ann Intern Med 82: 13–17, 1975.PubMedGoogle Scholar
  106. 106.
    Fisher BD, Armstrong D: Cryptococcal interstitial pneumonia. N Engl J Med 297: 1440–1441, 1977.PubMedGoogle Scholar
  107. 107.
    Newman RB, Stevens RW, Goafar HA: Latex agglutination test for the diagnosis of Haemophilus influenzae meningitis. J Lab Clin Med 76: 107–113, 1970.PubMedGoogle Scholar
  108. 108.
    Kaldor J, Asznowicz R, Burst DGP: Latex agglutination in diagnosis of bacterial infections, with special reference to patients with meningitis and septicemia. Am J Clin Pathol 68: 284–289, 1977.PubMedGoogle Scholar
  109. 109.
    Zimmerman SE, Smith JW: Identification and grouping of Neisseria meningitidis directly on agar plates by coagglutination with specific antibody-coated protein A-containing staphylococci. J Clin Microbiol 7: 470–473, 1978.PubMedGoogle Scholar
  110. 110.
    Edwards MS, Kasper DL, Baker CJ: Rapid diagnosis to type IE group B streptococcal meningitis by latex particle agglutination. J Pediatr 95: 202–205, 1979.PubMedGoogle Scholar
  111. 111.
    Berman NS, Siegel SE, Nachum P, et al: Cerebrospinal fluid endotoxin concentrations in gram-negative bacterial meningitis. J Pediatr 88: 553–556, 1976.PubMedGoogle Scholar
  112. 112.
    McCracken GH Jr: Rapid identification of specific etiology in meningitis. J Pediatr 88: 706–708, 1976.PubMedGoogle Scholar
  113. 113.
    Nachum R, Lipsey A, Siegel SE: Rapid detection of gram-negative bacterial meningitis by the limulus lysate test. N Engl J Med 289: 931–934, 1973.PubMedGoogle Scholar
  114. 114.
    Controni G, Rodrigues WJ, Hicks JM, et al: Cerebrospinal fluid lactic acid levels in meningitis. J Pediatr 91: 379–384, 1977.PubMedGoogle Scholar
  115. 115.
    Cates KL, Gerrard JM, Giebink GS, et al: A penicillin-resistant pneumococcus. J Pediatr 93: 624–626, 1978.PubMedGoogle Scholar
  116. 116.
    NIH Conscensus Conference: Intravenous immunoglobulin. Prevention and treatment of disease. JAMA 264: 3189–3193, 1990.Google Scholar
  117. 117.
    Roifman CM, Gelfand EW: Replacement therapy with high dose intravenous gamma-globulin improves chronic sinopulmonary disease in patients with hypogammaglobulinemia. Pediatr Infect Dis J 5: S92–S96, 1988.Google Scholar
  118. 118.
    Stiehm ER: New pediatric indications for IVIG. Contemp Pediatr 8: 29, 1991.Google Scholar
  119. 119.
    Henney CS, Ellis EF: Antibody production to aggregated human gamma-globulin in acquired hypogammaglobulinemia. N Engl J Med 278: 1144–1146, 1968.PubMedGoogle Scholar
  120. 120.
    Miller ME: Uses and abuses of plasma therapy in the patient with recurrent infections. J Allergy Clin Immunol 51: 45–56, 1973.PubMedGoogle Scholar
  121. 121.
    Cunningham-Rundles C, Siegel FP, Smithwick EM, et al: Efficacy of intravenous immunoglobulin in primary humoral immunodeficiency disease. Ann Intern Med 101: 435–439, 1984.PubMedGoogle Scholar
  122. 122.
    Condie RM, O’Reilly RJ: Prevention of cytomegalovirus infection by prophylaxis with an intravenous, hyperimmune, native unmodified cytomegalovirus globulin. Randomized trial in bone marrow transplant recipients. Am J Med 76(3A): 134–141, 1984.PubMedGoogle Scholar
  123. 123.
    Mease PJ, Ochs HD, Wedgewood RJ: Successful treatment of echovirus meningoencephalitis and myositis-fasciitis with intravenous immune globulin therapy in a patient with X-linked agammaglobulinemia. N Engl J Med 304: 1278–1281, 1981.PubMedGoogle Scholar
  124. 124.
    Stiehm ER, Vaerman JP, Fudenberg HH: Plasma infusions in immunologic deficiency states: Metabolic and therapeutic studies. Blood 28: 918–937, 1966.PubMedGoogle Scholar
  125. 125.
    Ammann AJ, Good RA, Bier D, et al: Long-term plasma infusions in a patient with ataxia—telangiectasia and deficient IgA and IgE. Pediatrics 44: 672–676, 1969.PubMedGoogle Scholar
  126. 126.
    Fudenberg HH, Spitter LE, Levin AS: Treatment of immune deficiency. Am J Pathol 69: 529–535, 1972.PubMedGoogle Scholar
  127. 127.
    Editorial: Chronic sinusitis. Lancet 1: 442–443, 1974.Google Scholar
  128. 128.
    Howie VM, Ploussard JH: Simultaneous nasopharyngeal and middle ear exudate cultures in otitis media. Pediatr Dig Feb: 31–35, 1971.Google Scholar
  129. 129.
    Ament ME: Immunodeficiency syndromes and gastrointestinal disease. Pediatr Clin North Am 22: 807–825, 1975.PubMedGoogle Scholar
  130. 130.
    Binder HJ, Reynolds RD: Control of diarrhea in secondary hypogammaglobulinemia by fresh plasma infusions. N Engl J Med 277: 802–803, 1967.PubMedGoogle Scholar
  131. 131.
    Schmalstieg FC: Leukocyte adherence defect. Pediatr Infect Dis J 7: 867–872, 1988.PubMedGoogle Scholar
  132. 132.
    Hill HR: Clinical disorders of leukocyte function. Contemp Topi Immunobiol 1984: 345–393, 1984.Google Scholar
  133. 133.
    Miles AA, Miles EM, Burke J: The value and duration of defense reactions of the skin to primary lodgement of bacteria. Br J Exp Pathol 38: 79–96, 1957.PubMedGoogle Scholar
  134. 134.
    Miles AA. The acute reaction of injury as an antimicrobial defense. In Thomas L, Uhr JW, Grant L (eds): International Symposium on Injury, Inflammation and Immunity. Baltimore, Williams & Wilkins, 1964, pp 162–182.Google Scholar
  135. 135.
    Clark RA, Root RK, Kimball HR, et al: Defective neutrophil chemotaxis and cellular immunity in a child with recurrent infections. Ann Intern Med 78: 515–519, 1973.PubMedGoogle Scholar
  136. 136.
    Horsburgh CR Jr, Kirkpatrick CH: Longterm therapy of chronic mucocutaneous candidiasis with ketoconazole: Experience with twenty-one patients. Am J Med 74: 23–29, 1983.PubMedGoogle Scholar
  137. 137.
    Horsburgh CR, Cannody PB, Kirkpatrick CH: Treatment of fungal infections in the bones and joints with ketoconazole. J Infect Dis 147: 1064–1069, 1983.PubMedGoogle Scholar
  138. 138.
    Viscoli C, Castagnola E, Fioredda F, et al: Fluconazole in the treatment of candidiasis in immunocompromised children. Antimicrob Agents Chemother 35: 365–367, 1991.PubMedGoogle Scholar
  139. 139.
    Ikemoto H: A clinical study of fluconazole for the treatment of deep mycoses. Diagn Microbiol Infect Dis 12: 239S–247S, 1989.PubMedGoogle Scholar
  140. 140.
    Sharkey PK, Rinaldi MG, Dunn JF, et al: High-dose itraconazole in the treatment of severe mycoses. Antimicrob Agents Chemother 35: 707–713, 1991.PubMedGoogle Scholar
  141. 141.
    Larsen RA, Leal MAE, Chan LS: Fluconazole compared with amphotericin B plus flucytosine for cryptococcal meningitis in AIDS. Ann Intern Med 113: 183–187, 1990.PubMedGoogle Scholar
  142. 142.
    Bozette SA, Larsen RA, Chiu J, et al: A placebo-controlled trial of maintenance therapy with fluconazole after treatment of cryptococcal meningitis in the acquired immunodeficiency syndrome. N Engl J Med 324: 580–584, 1991.Google Scholar
  143. 143.
    Wingard JR, Merz WG, Rinaldi MG, et al: Increase in Candida krusei infection among patients with bone marrow transplantation and neutropenia treated prophylactically with fluconazole. N Engl J Med 325: 1274–1277, 1991.PubMedGoogle Scholar
  144. 144.
    Wiebe VJ, DeGregorio MW: Liposome-encapsulated amphotericin B: A promising new treatment for disseminated fungal infections. Rev Infect Dis 10: 1097–1101, 1988.PubMedGoogle Scholar
  145. 145.
    Perrin JM, Charney E, MacWhinney JB, et al: Sulfisoxazole as chemoprophylaxis for recurrent otitis media. N Engl J Med 291: 664–667, 1974.PubMedGoogle Scholar
  146. 146.
    Hardin GM, Ronald AR: A controlled study of antimicrobial prophylaxis of recurrent urinary infections in women. N Engl J Med 291: 597–601, 1974.Google Scholar
  147. 147.
    Hughes WT, Kuhn S, Chaudhary S, et al: Successful chemoprophylaxis for Pneumocystis carinii pneumonitis. N Engl J Med 297: 1419–1426, 1977.PubMedGoogle Scholar
  148. 148.
    Johnston RB Jr, Wilfert CM, Buckley RH, et al: Enhanced bactericidal activity of phagocytes from patients with chronic granulomatous disease in the presence of sulphasoxazole. Lancet 1: 824–827, 1975.PubMedGoogle Scholar
  149. 149.
    Gonzalez LA, Hill HR: Advantages and disadvantages of anti-microbial prophylaxis in chronic granulomatous disease of childhood. Pediatr Infect Dis J 7: 83–85, 1988.PubMedGoogle Scholar
  150. 150.
    Kobayashi RH, Kobayashi AD, Lee N, et al: Home self-administration of intravenous immunoglobulin therapy in children. Pediatrics 85: 705–709, 1990.PubMedGoogle Scholar
  151. 151.
    Stiehm ER, Ashida E, Kim KS, et al: Intravenous immunoglobulins on therapeutic agents. Ann Intern Med 107: 367–382, 1987.PubMedGoogle Scholar
  152. 152.
    Ballow M, Dupont B, Good RA: Autoimmune hemolytic anemia in Wiskott-Aldrich syndrome during treatment with transfer factor. J Pediatr 83: 772–780, 1973.PubMedGoogle Scholar
  153. 153.
    Pabst HF, Swanson R: Successful treatment of candidiasis with transfer factor. Br Med J 2: 442–443, 1972.PubMedGoogle Scholar
  154. 154.
    Wybran J, Levin AS, Spitter LE, et al: Rosette-forming cells, immunologic deficiency diseases and transfer factor. N Engl J Med 288: 710–713, 1973.PubMedGoogle Scholar
  155. 155.
    Wara DW, Ammann AJ: Activation of T-cell rosettes in immunodeficient patients by thymosin. Ann NY Acad Sci 249: 308–314, 1975.PubMedGoogle Scholar
  156. 156.
    Goldstein AL, Cohen GH, Rossio JL, et al: Use of thymosin in the treatment of primary immunodeficiency diseases and cancer. Med Clin North Am 60: 591–606, 1976.PubMedGoogle Scholar
  157. 157.
    Polmar SH, Stern RC, Schwartz AL, et al: Enzyme replacement therapy for adenosine deaminase deficiency and severe combined immunodeficiency. N Engl J Med 295: 1337–1343, 1976.PubMedGoogle Scholar
  158. 158.
    Bortin MM, Rimm AA, et al: Severe combined immunodeficiency disease: Characterization of the disease and results of transplantation. JAMA 238: 591–600, 1977.PubMedGoogle Scholar
  159. 159.
    Hong R: Thymus transplants: a look to the future. Birth Defects 11: 357–360, 1975.PubMedGoogle Scholar
  160. 160.
    Buckley RH, Whisnant JK, Schiff RI, et al: Correction of severe combined immunodeficiency by fetal liver cells. N Engl J Med 294: 1076–1081, 1976.PubMedGoogle Scholar
  161. 161.
    Buckley RH: Immunoreconstitution, in Miller ME (ed): The Child with Recurrent Infection. Philadelphia, Saunders, 1977, pp 313–328.Google Scholar
  162. 162.
    Thomas FD, Stork R, Clift RA, et al: Bone-marrow transplantation. N Engl J Med 292: 832–843, 1975.PubMedGoogle Scholar
  163. 163.
    Levine AS, Siegel SE, Schreiber AD, et al: Protected environments and prophylactic antibodies. N Engl J Med 288: 477–483, 1973.PubMedGoogle Scholar
  164. 164.
    Cleveland WW: Immunologic reconstitution in the Di-George syndrome by fetal thymic transplant. Birth Defects 11: 352–356, 1975.PubMedGoogle Scholar
  165. 165.
    Ammann AJ, Wara DW, Doyle NE, et al: Thymus transplantation in patients with thymic hypoplasia and abnormal immunoglobulin synthesis. Transplantation 20: 457–466, 1975.PubMedGoogle Scholar
  166. 166.
    Kirkpatrick CH, Wells SA, Burdick JF, et al: Effects of fetal thymus transplantation on defective cellular immunity. Transplantation 20: 367–369, 1975.Google Scholar
  167. 167.
    Hill HR, Estensen RD, Quie PG, et al: Modulation of human neutrophil chemotactic responses by cyclic 3′5′-guanosine monophosphate and cyclic 3′5′-adenosine monophosphate. Metabolism 24: 447–456, 1975.PubMedGoogle Scholar
  168. 168.
    Zurier RB, Weissmann G, Hoffstein S, et al: Mechanism of lysosomal enzyme release from human leukocytes. II. Effects of cAMP and cGMP, autonomie agonists, and agents which affect microtubule function. J Clin Invest 53: 297–309, 1974.PubMedGoogle Scholar
  169. 169.
    Oliver, JM, Zurier RB: Correction of characteristic abnormalities of microtubule function and granule morphology in Chediak-Higashi syndrome with cholinergic agonists. J Clin Invest 57: 1239–1247, 1976.PubMedGoogle Scholar
  170. 170.
    Boyer LA, Watanabe AM, Rister M, et al: Correction of leukocyte function in Chediak-Higashi syndrome by ascorbate. N Engl J Med 295: 1041–1045, 1976.Google Scholar
  171. 171.
    Goetzel EJ, Wasserman SI, Gigli I, et al: Enhancement of random migration and chemotactic response of human leukocytes by ascorbic acid. J Clin Invest 53: 813–818, 1974.Google Scholar
  172. 172.
    Verhaegen H, DeCree J, Cock WD, et al: Levamisole and the immune response. N Engl J Med 289: 1148–1149, 1973.Google Scholar
  173. 173.
    Hoekeke J, Franchi G: Influence of tetramisole and its optical isomers on the mononuclear phagocytic system. Effect on carbon clearance in mice. J Reticuloendothel Soc 14: 317–323, 1973.Google Scholar
  174. 174.
    Pike MC, Snyderman R: Augmentation of human monocyte chemotactic response by levamisole. Nature 201: 136–137, 1976.Google Scholar
  175. 175.
    Hogan NA, Hill HR: Levamisole enhances PMN chemotaxis and elevates cellular cyclic GMP. J Infect Dis 138: 437–444, 1978.PubMedGoogle Scholar
  176. 176.
    Wright DG, Kirkpatrick CH, Gallin JI: Effects of levamisole on normal and abnormal leukocyte locomotion. J Clin Invest 59: 941–950, 1977.PubMedGoogle Scholar
  177. 177.
    Rosenthal M, Trabert U, Muller W: Leukocytotoxic effect of levamisole. Lancet 1: 369, 1976.PubMedGoogle Scholar
  178. 178.
    The International Chronic Granulomatous Disease Cooperative Study Group: A controlled trial of interferon gamma to prevent infection in chronic granulomatous disease. N Engl J Med 324: 509–516, 1991.Google Scholar
  179. 179.
    Jeppson JD, Jaffe HS, Hill HR: Use of recombinant human interferon gamma to enhance neutrophil chemotactic responses in Job syndrome of hyperimmunoglobulinemia E and recurrent infections. J Pediatr 118: 383–387, 1991.PubMedGoogle Scholar
  180. 180.
    Hughes WT, Feldman S, Chaundhary SC, et al: Comparison of pentamidine isethionate and trimethoprim-sulfamethoxazole in the treatment of Pneumocystis carinii pneumonia. J Pediatr 92: 285–291, 1978.PubMedGoogle Scholar
  181. 181.
    Lau WK, Young LS: Trimethoprim-sulfamethoxazole treatment of Pneumocystis carinii pneumonia in adults. N Engl J Med 295: 716–718, 1976.PubMedGoogle Scholar
  182. 182.
    Larter WE, John TJ, Sieber OF Jr, et al: Trimethoprim-sulfamethoxazole treatment of Pneumocystis carinii pneumonitis. J Pediatr 92: 826–828, 1978.PubMedGoogle Scholar
  183. 183.
    Walzer PD, Perl DP, Krogstad PJ, et al: Pneumocystis carinii pneumonia in the United States: Epidemiologic, diagnostic, and clinical features. Ann Intern Med 80: 83–93, 1974.PubMedGoogle Scholar
  184. 184.
    Montaner JSF, Lawson LM, Levitt N, et al: Corticosteroids prevent early deterioration in patients with moderately severe Pneumocystis carinii pneumonia and the acquired immunodeficiency syndrome (AIDS). Ann Intern Med 113: 14–20, 1990.PubMedGoogle Scholar
  185. 185.
    Soo Hoo GW, Mohserifar Z, Meyer RD: Inhaled or intravenous pentamidine therapy for Pneumocystis carinii pneumonia in AIDS. A randomized trial. Ann Intern Med 113: 195–202, 1990.PubMedGoogle Scholar
  186. 186.
    Hirschel B, Lazzarin A, Chopard P, et al: A controlled study of inhaled pentamidine for primary prevention of Pneumocystis carinii pneumonia. N Engl J Med 324: 1079–1083, 1991.PubMedGoogle Scholar
  187. 187.
    Watanakunakorn C, Glotzbecker C: Enhancement of the effects of antistaphylococcal antibiotics by aminoglycosides. Antimicrob Agents Chemother 6: 802–806, 1974.Google Scholar
  188. 188.
    Curry CR, Quie PG: Fungal septicemia in patients receiving parenteral hyperalimentation. N Engl J Med 285: 1221–1225, 1971.PubMedGoogle Scholar
  189. 189.
    Montgomerie JZ, Edwards JE Jr: Association of infection due to Candida albicans with intravenous hyperalimentation. J Infect Dis 1978: 197–201, 1978.Google Scholar
  190. 190.
    Hill HR, Mitchell TG, Matsen JM, et al: Recovery from disseminated candidiasis in a premature neonate. Pediatrics 53: 748–752, 1974.PubMedGoogle Scholar
  191. 191.
    Shepp DH, Dandliker PS, Meyers JD: Current therapy of varicella zoster virus infection in immunocompromised patients. A comparison of acyclovir and vidarabine. Am J Med 85(suppl 2A): 96–98, 1988.PubMedGoogle Scholar
  192. 192.
    Buhles WC Jr, Mastre BJ, Tinker AJ, et al: Ganciclovir treatment of life-or sight-threatening cytomegalovirus infection: Experience in 314 immunocompromised patients. Rev Infect Dis 10: S495–S506, 1988.PubMedGoogle Scholar
  193. 193.
    Parkman R, Gelfand EW, Rosen FS, et al: Severe combined immunodeficiency and adenosine deaminase deficiency. N Engl J Med 292: 714–719, 1975.PubMedGoogle Scholar
  194. 194.
    Stoop JW, Zegers BJM, Hendricks GFM, et al: Purine nucleoside phosphorylase deficiency associated with selective cellular immunodeficiency. N Engl J Med 96: 651–655, 1977.Google Scholar
  195. 195.
    Ackeret C, Pluss HJ, Hitzig WH: Hereditary severe combined immunodeficiency and adenosine deaminase deficiency. Pediatr Res 10: 67–70, 1976.PubMedGoogle Scholar
  196. 196.
    Lum LG, Tubergen DG, Corasti L, et al: Splenectomy in the management of the thrombocytopenia of the Wiskott-Aldrich syndrome. N Engl J Med 302: 892–896, 1980.PubMedGoogle Scholar
  197. 197.
    Stiehm ER: Plasma therapy: An alternative to gamma globulin injections in immunodeficiency. Birth Defects 11: 343–346, 1975.PubMedGoogle Scholar
  198. 198.
    Greenberg AH, Ray M, Tsai YT: Thymic alymphoplasia and dysgammaglobulinemia type I. Clinical, immunologic, and pathologic studies of one case. J Pediatr 75: 95–103, 1969.PubMedGoogle Scholar
  199. 199.
    Allibone EC, Goldie W, Marmon BP: Pneumocystis carinii pneumonia and progressive vaccines in siblings. Arch Dis Child 39: 26–34, 1964.PubMedGoogle Scholar
  200. 200.
    Wara DW, Goldstein AL, Doyle NE, et al: Thymosin activity in patients with cellular immunodeficiency. N Engl J Med 292: 70–74, 1975.PubMedGoogle Scholar
  201. 201.
    Tiller TL Jr, Buckley RN: Transient hypogammaglobulinemia of infancy: Review of the literature, clinical and immunologic features of 11 new cases, and long-term followup. J Pediatr 92: 347–353, 1978.PubMedGoogle Scholar
  202. 202.
    Bruton OC: Agammaglobulinemia. Pediatrics 9: 722–728, 1952.PubMedGoogle Scholar
  203. 203.
    Davis SD: Antibody deficiency diseases. In Stiehm ER, Fulginiti VA (eds): Immunologic Disorders in Infants and Children. Philadelphia, Saunders, 1973, pp 184–198.Google Scholar
  204. 204.
    Wilfert CM, Buckley RH, Mohammakeimar T, et al: Persistent and fatal central-nervous-system echovirus infections in patients with agammaglobulinemia. N Engl J Med 26: 1485–1489, 1977.Google Scholar
  205. 205.
    Levitt D, Haber P, Rich K, et al: Hyper IgM immunodeficiency. J Clin Invest 72: 1650–1657, 1983.PubMedGoogle Scholar
  206. 206.
    Ammann AJ, Hong R: Selective IgA deficiency. In Stiehm ER, Fulginiti VA (eds): Immunologic Disorders in Infants and Children. Philadelphia, Saunders, 1973, pp 199–214.Google Scholar
  207. 207.
    Strober W, Krakauer R, Klaeveman HL, et al: Secretory component deficiency: A disorder of the IgA immune system. N Engl J Med 294: 351–356, 1976.PubMedGoogle Scholar
  208. 208.
    Ammann AJ, Hong R: Selective IgA deficiency: Presentation of 30 cases and a review of the literature. Medicine (Baltimore) 50: 223–226, 1971.Google Scholar
  209. 209.
    South MA, Cooper MD, Wollheim FA, et al: The IgA system. II. The clinical significance of IgA deficiency: Studies in patients with agammaglobulinemia and ataxia-telangiectasia. Am J Med 44: 168–178, 1978.Google Scholar
  210. 210.
    Douglas SD, Goldberg LS, Fudenberg HH: Clinical, serologic and leukocyte function studies on patients with idiopathic “acquuired” agammaglobulinemia and their families. Medicine (Baltimore) 48: 48–53, 1970.Google Scholar
  211. 211.
    Day NK, Geiger H, Stroud R, et al: Clr deficiency: An inborn error associated with cutaneous and renal disease. J Clin Invest 51: 1102–1108, 1972.PubMedGoogle Scholar
  212. 212.
    Klemperer MR, Woodworm HC, Rosen FS, et al: Hereditary deficiency of the second component of complement (C’2) in man. J Clin Invest 45: 880–890, 1966.PubMedGoogle Scholar
  213. 213.
    Osterland CK, Espinoza L, Parker LP, et al: Inherited C2 deficiency and systemic lupus erythematosus studies on a family. Ann Intern Med 82: 323–328, 1975.PubMedGoogle Scholar
  214. 214.
    Gilliland BC, Schaller JG, Leddy JP, et al: Lupus syndrome in a C4-deficient child. Arthritis Rheum 18: 401, 1975.Google Scholar
  215. 215.
    Newman SL, Vogler LB, Feigin RD, et al: Recurrent septicemia associated with congenital deficiency of C2 and partial deficiency of factor B and the alternative complement. N Engl J Med 299: 290–292, 1978.PubMedGoogle Scholar
  216. 216.
    Alper CA, Colton HR, Rosen FS, et al: Homozygous deficiency of C3 in a patient with repeat infections. Lancet 2: 1179–1181, 1972.PubMedGoogle Scholar
  217. 217.
    Miller ME, Nilsson UR: A familial deficiency of the phagocytosis-enhancing activity of serum related to a dysfunction of the fifth component of complement (C5). N Engl J Med 282: 354–358, 1970.PubMedGoogle Scholar
  218. 218.
    Miller ME, Kablenzer PG: Leiner’s disease and deficiency of C5. J Pediatr 80: 879–880, 1972.PubMedGoogle Scholar
  219. 219.
    Leiner C: Uber Erythrodermia desquamativa, eine Eigenartige universelle Dermatose der Brustkinder. Arch Dermatol Syph 89: 163, 1908.Google Scholar
  220. 220.
    Hill HR, Hogan NA, Bale JF, et al: Evaluation of non-specific (alternative pathway) opsonic activity by neutrophil chemiluminescence. Int Arch Allergy Appl Immunol 53: 490–497, 1977.PubMedGoogle Scholar
  221. 221.
    Neu RL, Stockman JA III, Spitzer RE, et al: 46, XY/46, XY, 21q-mosaicism in an infant with neutropenia and properdin deficiency. J Med Genet 13: 332–334, 1976.PubMedGoogle Scholar
  222. 222.
    Bodey GP, Buckley M, Sathe YS, et al: Quantitative relationships between circulating leukocytes and infection in patients with acute leukemia. Ann Intern Med 64: 328–340, 1966.PubMedGoogle Scholar
  223. 223.
    Stossel TP: Phagocytosis. N Engl J Med 290: 717–723, 1974.PubMedGoogle Scholar
  224. 224.
    Van De Meer JWM, Van Den Brock PJ: Present status of the management of patients with defective phagocyte function. Rev Infect Dis 6: 107–121, 1984.PubMedGoogle Scholar
  225. 225.
    Kauder E, Mauer AM: Neutropenias of childhood. J Pediatr 69: 147–157, 1966.PubMedGoogle Scholar
  226. 226.
    Kostmann R: Infantile genetic agranulocytosis. Acta Paediatr 45: 1–78, 1956.Google Scholar
  227. 227.
    Borilla MA, Gillio AP, Ruggeiro M, et al: Effects of recombinant human granulocyte colony-stimulating factor on neutropenia in patients with congenital agranulocytosis. N Engl J Med 320: 1574–1580, 1989.Google Scholar
  228. 228.
    Zuelzer WW, Bajoghli M: Chronic granulocytopenia in childhood. Blood 23: 359–374, 1964.PubMedGoogle Scholar
  229. 229.
    Roskos RR, Boxer LA: Clinical disorders of neutropenia. Pediatr Rev 12: 208–212, 1991.PubMedGoogle Scholar
  230. 230.
    Miller ME, Norman ME, Koblenzer PJ, et al: A new familial defect of neutrophil movement. J Lab Clin Med 82: 1–8, 1973.PubMedGoogle Scholar
  231. 231.
    Dahl MV, Greene WH Jr, Quie PG: Infection, dermatitis, increased IgE, and impaired neutrophil chemotaxis. Arch Dermatol 112: 1387–1390, 1976.PubMedGoogle Scholar
  232. 232.
    Jacobs JC, Norman ME: A familial defect of neutrophil chemotaxis with asthma, eczema, and recurrent skin infections. Pediatr Res 11: 732–736, 1977.PubMedGoogle Scholar
  233. 233.
    Hill HR: The syndrome of hyperimmunoglobulinemia E and recurrent infections. Am J Dis Child 136: 767–771, 1982.PubMedGoogle Scholar
  234. 234.
    Hill HR, Estensen RD, Hogan NA, et al: Severe staphylococcal disease associated with allergic manifestations, hyperimmunoglobulinemia E, and defective neutrophil chemotaxis. J Lab Clin Med 88: 796–806, 1976.PubMedGoogle Scholar
  235. 235.
    Hill HR, Williams PB, Krueger GG, et al: Recurrent staphylococcal abscesses associated with defective neutrophil chemotaxis and allergic rhinitis. Ann Intern Med 85: 39–43, 1976.PubMedGoogle Scholar
  236. 236.
    Buckley RH, Wray BB, Belmaker EZ: Extreme hyperimmunoglobulinemia E and undue susceptibility to infection. Pediatrics 49: 59–69, 1972.PubMedGoogle Scholar
  237. 237.
    Davis SD, Schaller J, Wedgwood RJ: Job’s syndrome: Recurrent, “cold,” staphylococcal abscesses. Lancet 1: 1013–1017, 1966.PubMedGoogle Scholar
  238. 238.
    Rubin JL, Griffiths RW, Hill HR: Allergen induced depression of neutrophil chemotaxis in allergic individuals. J Allergy Clin Immunol 62: 301–308, 1978.PubMedGoogle Scholar
  239. 239.
    Schopfer K, Baerlocher K, Price P, et al: Staphylococcal IgE antibodies, hyperimmunoglobulinemia E and Staphylococcal aureus infections. N Engl J Med 300: 835–838, 1979.PubMedGoogle Scholar
  240. 240.
    Butler HL, Byrne WJ, Marmer DJ, et al: Depressed neutrophil chemotaxis in infants with cow’s milk and/or soy protein intolerance. Pediatrics 67: 264–268, 1981.PubMedGoogle Scholar
  241. 241.
    Donabedian H, Ailing DW, Vallin JI: Levamisole is inferior to placebo in the hyperimmunoglobulin E recurrent infection (Job’s) syndrome. N Engl J Med 307: 290–292, 1982.PubMedGoogle Scholar
  242. 242.
    Mawhinney H, Killen M, Fleming WA, et al: The hyperimmunoglobulinemia E syndrome—A neutrophil chemotactic defect reversible by histamine H2 receptor blockade?. Clin Immunol Immunopathol 17: 483–491, 1980.PubMedGoogle Scholar
  243. 243.
    Soderberg-Warner M, Rice-Mendoza CA, Mendoza GR, et al: Neutrophil and T lymphocyte characteristics of two patients with the hyper IgE syndrome. Pediatr Res 17: 820–824, 1983.PubMedGoogle Scholar
  244. 244.
    Björksten B, Lundmark KM: Recurrent bacterial infections in four siblings with neutropenia, eosinophilia, hyperimmunoglobulinemia A, and defective neutrophil chemotaxis. J Infect Dis 133: 63–71, 1976.PubMedGoogle Scholar
  245. 245.
    Boxer LA, Hedley-Whyte ET, Stossel TP: Neutrophil actin dysfunction and abnormal neutrophil behavior. N Engl J Med 291: 1093–1099, 1974.PubMedGoogle Scholar
  246. 246.
    Snyderman R, Altman LC, Frankel A, et al: Defective mono-nuclear leukocyte chemotaxis: A previously unrecognized immune dysfunction. Ann Intern Med 78: 509–513, 1973.PubMedGoogle Scholar
  247. 247.
    Gallin JL: Abnormal chemotaxis: Cellular and humoral components. In Bellanti JA, Dayton DH (eds): The Phagocytic Cell in Host Resistance. Raven, New York; 1975; pp 227–248.Google Scholar
  248. 248.
    Klebanoff SJ: Myeloperoxidase-halide-hydrogen peroxidase antimicrobial system. J Bacteriol 95: 2131–2138, 1968.PubMedGoogle Scholar
  249. 249.
    Gray GR, Klebanoff SJ, Stamatoyannopoulos G, et al: Neutrophil dysfunction, chronic granulmatous disease, and non-spherocytic haemolytic anaemia caused by complete deficiency of glucose-6-phosphate dehydrogenase. Lancet 2: 530–534, 1973.PubMedGoogle Scholar
  250. 250.
    Kaplan EL, Laxdal T, Quie PG: Studies on polymorphonuclear leukocytes from patients with chronic granulomatous disease of childhood: Bactericidal capacity for streptococci. Pediatrics 41: 591–599, 1968.PubMedGoogle Scholar
  251. 251.
    Raubitschak AA, Levin AS, Stites DP, et al: Normal granulocyte infusion therapy for aspergillosis in chronic granulomatous disease. Pediatrics 51: 230–233, 1973.Google Scholar
  252. 252.
    Verronen P: Presumed disseminated BCG in a boy with chronic granulomatous disease of childhood. Acta Pediatr Scand 63: 627–630, 1974.Google Scholar
  253. 253.
    Cohen MS, Isturiz RE, Malech HL, et al: Fungal infection in chronic granulomatous disease. Am J Med 71: 59–66, 1981.PubMedGoogle Scholar
  254. 254.
    O’Neil KM, Herman JH, Modlin JF, et al: Pseudomonas cepacia: An emerging pathogen in chronic granulomatous disease. J Pediatr 108: 940–942, 1986.PubMedGoogle Scholar
  255. 255.
    Quie PG: Infections due to neutrophil malfunction. Medicine 52: 411–417, 1973.PubMedGoogle Scholar
  256. 256.
    Salmon SE, Cline MJ, Schultz J, et al: Myeloperoxidase deficiency. N Engl J Med 282: 250–253, 1970.PubMedGoogle Scholar
  257. 257.
    Medoff G, Dismicker WE, Meade RH, et al: A new therapeutic approach to Candida infections. Arch Intern Med 130: 241–249, 1972.PubMedGoogle Scholar
  258. 258.
    Gregory L, Williams R, Thompson E: Leukocyte function in Down’s syndrome and acute leukemia. Lancet 1: 1359–1361, 1977.Google Scholar
  259. 259.
    Rosner F, Kozinn PJ, Jervis GA: Leukocyte function and serum immunoglobulins in Down’s syndrome. NY State J Med 73: 672–675, 1973.Google Scholar
  260. 260.
    Klein RB, Fischer TJ, Gard SE, et al: Decreased mononuclear and ploymorphonuclear chemotaxis in human newborns, infants, and young children. Pediatrics 60: 467–472, 1977.PubMedGoogle Scholar
  261. 261.
    Miller ME: Chemotactic function in the human neonate: Humoral and cellular aspects. Pediatr Res 5: 587–592, 1971.Google Scholar
  262. 262.
    Tono-Oda T, Nakayama M, Uehara H, et al: Characteristics of impaired chemotactic function in cord blood leukocytes. Pediatr Res 13: 148–151, 1979.Google Scholar
  263. 263.
    Mills EL, Thompson T, Bjôrksten B, et al: The chemiluminescence response and bactericidal activity of polymorphonuclear neutrophils from newborns and their mothers. Pediatrics 63: 429–434, 1979.PubMedGoogle Scholar
  264. 264.
    Wright WC Jr., Ank BJ, Herbert J, et al: Decreased bactericidal acitivity of leukocytes of stressed newborn infants. Pediatrics 56: 579–584, 1975.PubMedGoogle Scholar
  265. 265.
    Bortolussi R, Thompson TR, Ferrieri P: Early-onset pneumococcal sepsis in newborn infants. Pediatrics 60: 352–355, 1977.PubMedGoogle Scholar
  266. 266.
    Filice GA, Cantrell HF, Smith AB, et al: Listeria monocytogenes infection in neonates: Investigation of an epidemic. J Infect Dis 138: 17–23, 1978.PubMedGoogle Scholar
  267. 267.
    Headings DL, Overall JC Jr: Outbreak of meningitis in a newborn intensive care unit caused by a single Escherichia coli K1 serotype. J Pediatr 90: 99–102, 1977.PubMedGoogle Scholar
  268. 268.
    Hemming VG, McClosky DW, Hill HR: Pneumonia in the neonate associated with group B streptococcal septicemia. Am J Dis Child 130: 1231–1233, 1976.PubMedGoogle Scholar
  269. 269.
    Hill HR, Hunt CE, Matsen JM: Nosocomial colonization with Klebsella type 26 in a neonatal intensive care unit associated with an outbreak of sepsis, meningitis and necrotizing enterocolitis. J Pediatr 85: 415–419, 1974.PubMedGoogle Scholar
  270. 270.
    Pickering LK, Simon FA: Reevaluation of neonatal Haemophilus influenzae infections. South Med J 70: 205–208, 1977.PubMedGoogle Scholar
  271. 271.
    Hill HR: Host defenses in the neonate: Prospects for enhancement. Semin Perinatol 9: 2–11, 1985.PubMedGoogle Scholar
  272. 272.
    Hill HR: Diagnosis and treatment of sepsis in the neonate. In Root RK, Sande MA (eds): Septic Shock. Churchill Livingstone, New York; 1985; pp 219–232.Google Scholar
  273. 273.
    Shigeoka AO, Hall RT, Hill H: Blood-transfusion in group-B streptococcal sepsis. Lancet 1: 636–638, 1978.PubMedGoogle Scholar
  274. 274.
    Gonzalez LA, Hill HR: The current status of intravenous gammaglobulin use in neonates. Pediatr Infect Dis J 8: 315–322, 1989.PubMedGoogle Scholar
  275. 275.
    Hill HR: Granulocyte transfusions in neonates. Pediatr Rev 12: 298–302, 1991.PubMedGoogle Scholar

Copyright information

© Plenum Publishing Corporation 1994

Authors and Affiliations

  • John C. Christenson
    • 1
  • Harry R. Hill
    • 2
  1. 1.Department of Pediatrics, Division of Infectious DiseasesUniversity of Utah School of MedicineSalt Lake CityUSA
  2. 2.Departments of Pediatrics and Pathology, Division of Clinical Immunology and AllergyUniversity of Utah School of MedicineSalt Lake CityUSA

Personalised recommendations